Download PDF
Thromb Haemost 1965; 13(01): 012-024
DOI: 10.1055/s-0038-1656283
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Circulating Fibrinogen Degradation Products (FDP) in Dog Blood after Intravenous Thrombin Infusion

E Kowalski
1   Department of Radiobiology and Health Protection, Institute of Nuclear Research Warsaw 9
,
A. Z Budzyński
1   Department of Radiobiology and Health Protection, Institute of Nuclear Research Warsaw 9
,
Maria Kopeć
1   Department of Radiobiology and Health Protection, Institute of Nuclear Research Warsaw 9
,
Z. S Latallo
1   Department of Radiobiology and Health Protection, Institute of Nuclear Research Warsaw 9
,
B Lipiński
1   Department of Radiobiology and Health Protection, Institute of Nuclear Research Warsaw 9
,
Z Węgrzynowicz
1   Department of Radiobiology and Health Protection, Institute of Nuclear Research Warsaw 9
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

    Permissions and Reprints

Summary

1. The effect of thrombin infusion into dogs was studied with the use of 131I-labelled fibrinogen and compared with the better known effect of plasmin.

2. Rapid infusion of thrombin brings about almost complete defibrination followed by the appearance of high molecular fragments of the fibrinogen molecule.

3. Some anticoagulant activity of plasma, but not as pronounced as after plasmin infusion, is observed in the case of thrombin infusion.

4. A hypothesis is discussed, according to which the proteolytic degradation of fibrin which is formed as a result of thrombin action, and cleared out of the circulating blood, does occur. The products are then released back into the circulation system.

 

  • References

  • 1 Astrup T, Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch. Bio-chem. 40: 346 1952;
    CrossrefPubMedGoogle Scholar
  • 2 Blombach B, Blombach M. Purification of human and bovine fibrinogen. Arkiv for Kemi. iö: 415 1956
    PubMed
  • 3 Budzynski A. Z, Lipinski B, Batallo Z. S. Unpublished results
    PubMed
  • 4 Copley A. L. Studies on human placental thromboplastin in vitro and in vivo. Science 101: 436 1945;
    CrossrefPubMedGoogle Scholar
  • 5 Fulton L. D, Page E. W. Nature of the refractory state following sublethal closes of human placental thromboplastin. Proc. Soc. exp. Biol. 68: 594 1948;
    CrossrefPubMedGoogle Scholar
  • 6 Hardaway R. M. The role of intravascular clotting in the etiology of shock. Ann. Surg. 155: 325 1962;
    CrossrefPubMedGoogle Scholar
  • 7 Hardaway R, Brune W, Greever E, Burns J, Mock H. Studies on the role of intravascular coagulation in irreversible hemorrhagic shock. Ann. Surg. 155: 241 1962;
    CrossrefPubMedGoogle Scholar
  • 8 Hardaway R. M, Weiss F. H. Intracapillary clotting as the etiology of shock. Arch. Surg. 83: 851 1961;
    CrossrefPubMedGoogle Scholar
  • 9 Hardaway R. M, Watson H. E, Weiss F. H. Alterations in blood coagulation mechanism after intra-aortic injection of thrombin. Arch. Surg. 81: 983 1960;
    CrossrefPubMedGoogle Scholar
  • 10 Jürgens R, Studer A. Zur Wirkung des Thrombins. Helv. physiol. pharmacol. Acta 6: 134 1948;
    PubMedGoogle Scholar
  • 11 Kekwick R. A, Mackay M. E, Nance M. H, Record B. R. The purification of human fibrinogen. Biochem. J. 60: 671 1955;
    PubMedGoogle Scholar
  • 12 Kline D. L. The purification and cristallization of plasminogen (Profibrinolysin). J. Biol. Chem. 204: 949 1953;
    PubMedGoogle Scholar
  • 13 Kotschy M. O. O aktywacji plazminy w krzepnacej krwi Postepy Hig. Med. dosw. 18: 45 1964;
    PubMedGoogle Scholar
  • 14 Kowalski E, Budzynski A. Z, Kopec Maria, Batallo Z. S, Lipinski B, Wçgrzynowicz Z. Studies on the molecular pathology and pathogenesis of bleeding in severe fibrinolytic states in dogs. Thrombos. Diathes. haemorrh. (Stuttg.) 12: 69 1964;
    PubMedGoogle Scholar
  • 15 Kowarzyk H, Kotschy M. Clot formation and fibrinolysis. Congress of Purkynie Czecoslovak. Med. Soc. Prague, 1962. (In press.)
    PubMed
  • 16 Kudriaszow B. A, Ulytina P. D. Existence and significance of a physiological anticoagulat-ing system. Nature 182: 397 1958;
    PubMedGoogle Scholar
  • 17 Kudriaszow B. A, Ulytina P. D. Interrelations between the blood coagulating system and the physiological anticoagulating system. Nature 184: 4684 1959;
    PubMedGoogle Scholar
  • 18 Lipinski B, Budzynski A. Z, Batallo Z. S, Kowalski E. Isolation and characterisation of cold-insoluble fibrinogen complex from bovine plasma. Acta biochim. pol. 11: 527 1964;
    PubMedGoogle Scholar
  • 19 Loewy A. G, Dunathan K, Kriel R, Wolfinger Jr H. L. Fibrinase I. Purification of substrate and enzyme. J. biol. Chem. 236: 2625 1961;
    PubMedGoogle Scholar
  • 20 Mills G. A. The action of tissue extracts in the coagulation of blood. J. biol. Chem. 46: 167 1921;
    PubMedGoogle Scholar
  • 21 Monkhouse F. G, Milojevie S. Changes in fibrinogen level after infusion of thrombin and thromboplastin. Amer. J. Physiol. 199: 1165 1960;
    PubMedGoogle Scholar
  • 22 Niewiarowska M, Wçgrzynowicz Z. Influence of dicumarol derivatives on plasma fibrinolytic system. Thrombos. Diathes. haemorrh. (Stuttg.) 3: 297 1959;
    PubMedGoogle Scholar
  • 23 Ratnojf O. D, Conley G. L. Studies on a fibrinogenemia. II. The defibrinating effect on dog blood of intravenous injection of thromboplastic material. Bull. Johns Hopk. Hosp. 88: 414 1951;
    PubMedGoogle Scholar
  • 24 Sawyer W. D, Fletcher A. P, Alkjaersig N, Sherry S. Studies on the thrombolytic activity of human plasma. J. clin. Invest. 39: 426 1960;
    CrossrefPubMedGoogle Scholar
  • 25 Schneider C. L. The active principle of placental toxin: thromboplastin; its inactivation in blood: antithromboplastin. Amer. J. Physiol. 149: 123 1947;
    PubMedGoogle Scholar
  • 26 Thomas L. Studies on the intravascular thromboplastic effect of tissue suspension in mice. I. The reaction of mice to intravenous injection of a sedimentable tissue component. Bull. Johns Hopk. Hosp. 81: 1 1947;
    PubMedGoogle Scholar